A Clinical and Physiological Prospective Observational Study on the Management of Pediatric Shock in the Post-Fluid Expansion as Supportive Therapy Trial Era.
Journal
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
ISSN: 1529-7535
Titre abrégé: Pediatr Crit Care Med
Pays: United States
ID NLM: 100954653
Informations de publication
Date de publication:
01 07 2022
01 07 2022
Historique:
pubmed:
22
4
2022
medline:
12
7
2022
entrez:
21
4
2022
Statut:
ppublish
Résumé
Fluid bolus resuscitation in African children is harmful. Little research has evaluated physiologic effects of maintenance-only fluid strategy. We describe the efficacy of fluid-conservative resuscitation of septic shock using case-fatality, hemodynamic, and myocardial function endpoints. Pediatric wards of Mbale Regional Referral Hospital, Uganda, and Kilifi County Hospital, Kenya, conducted between October 2013 and July 2015. Data were analysed from August 2016 to July 2019. Children (≥ 60 d to ≤ 12 yr) with severe febrile illness and clinical signs of impaired perfusion. IV maintenance fluid (4 mL/kg/hr) unless children had World Health Organization (WHO) defined shock (≥ 3 signs) where they received two fluid boluses (20 mL/kg) and transfusion if shock persisted. Clinical, electrocardiographic, echocardiographic, and laboratory data were collected at presentation, during resuscitation and on day 28. Outcome measures were 48-hour mortality, normalization of hemodynamics, and cardiac biomarkers. Thirty children (70% males) were recruited, six had WHO shock, all of whom died (6/6) versus three of 24 deaths in the non-WHO shock. Median fluid volume received by survivors and nonsurvivors were similar (13 [interquartile range (IQR), 9-32] vs 30 mL/kg [28-61 mL/kg], z = 1.62, p = 0.23). By 24 hours, we observed increases in median (IQR) stroke volume index (39 mL/m 2 [32-42 mL/m 2 ] to 47 mL/m 2 [41-49 mL/m 2 ]) and a measure of systolic function: fractional shortening from 30 (27-33) to 34 (31-38) from baseline including children managed with no-bolus. Children with WHO shock had a higher mean level of cardiac troponin ( t = 3.58; 95% CI, 1.24-1.43; p = 0.02) and alpha-atrial natriuretic peptide ( t = 16.5; 95% CI, 2.80-67.5; p < 0.01) at admission compared with non-WHO shock. Elevated troponin (> 0.1 μg/mL) and hyperlactatemia (> 4 mmol/L) were putative makers predicting outcome. Maintenance-only fluid therapy normalized clinical and myocardial perturbations in shock without compromising cardiac or hemodynamic function whereas fluid-bolus management of WHO shock resulted in high fatality. Troponin and lactate biomarkers of cardiac dysfunction could be promising outcome predictors in pediatric septic shock in resource-limited settings.
Identifiants
pubmed: 35446796
doi: 10.1097/PCC.0000000000002968
pii: 00130478-202207000-00004
pmc: PMC7613033
mid: EMS146167
doi:
Substances chimiques
Biomarkers
0
Troponin
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
502-513Subventions
Organisme : Medical Research Council
ID : MR/R018502/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0601027
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 100693
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0801439
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203077
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 105603
Pays : United Kingdom
Organisme : EPA
ID : EP-C-15-003
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Déclaration de conflit d'intérêts
Drs. Obonyo, Olupot-Olupot, and Uyoga are funded and supported through the Wellcome Trust and the Department for International Development funded DELTAS Africa Initiative (DEL-15-003). Dr. Obonyo received funding from Imperial College London (Institutional Strategic Support Funds [105603/Z/14/Z]) and Wellcome Trust Imperial College Centre for Global Health Research [100693/Z/12/Z]) and the Initiative to Develop African Research Leaders/Kenya Medical Research Institute-Wellcome Trust Research Programme. Dr. Chebet received funding from Mbale Clinical Research Institute. Drs. Olupot-Olupot, Nteziyaremye, Muhindo, and Maitland received support for article research from Research Councils UK. Drs. Nteziyaremye, Chebet, Muhindo, and Maitland received support for article research from Wellcome Trust/Charity Open Access Fund. Dr. Maitland received funding from Wellcome East African Overseas Programme Award from the Wellcome Trust (203077/Z/16/Z). The remaining authors have disclosed that they do not have any potential conflicts of interest.
Références
Cruz AT, Lane RD, Balamuth F, et al.: Updates on pediatric sepsis. J Am Coll Emerg Physicians Open. 2020; 1:981–993
Moisi JC, Gatakaa H, Berkley JA, et al.: Excess child mortality after discharge from hospital in Kilifi, Kenya: A retrospective cohort analysis. Bull World Health Organ. 2011; 89:725–32, 732A
Maitland K, Kiguli S, Opoka RO, et al.; FEAST Trial Group: Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011; 364:2483–2495
Maitland K, George EC, Evans JA, et al.; FEAST trial group: Exploring mechanisms of excess mortality with early fluid resuscitation: Insights from the FEAST trial. BMC Med. 2013; 11:68
Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses. Geneva, Switzerland, World Heatlh Organization, 2013
Houston KA, George EC, Maitland K: Implications for paediatric shock management in resource-limited settings: A perspective from the FEAST trial. Crit Care. 2018; 22:119
Kiguli S, Akech SO, Mtove G, et al.: WHO guidelines on fluid resuscitation in children: Missing the FEAST data. BMJ. 2014; 348:f7003
Maitland K, Molyneux S, Boga M, et al.: Use of deferred consent for severely ill children in a multi-centre phase III trial. Trials. 2011; 12:90
von Elm E, Altman DG, Egger M, et al.; STROBE Initiative: The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Ann Intern Med. 2007; 147:573–577
Kligfield P, Gettes LS, Bailey JJ, et al.; American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; American College of Cardiology Foundation; Heart Rhythm Society: Recommendations for the standardization and interpretation of the electrocardiogram: Part I: The electrocardiogram and its technology: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the International Society for Computerized Electrocardiology. Circulation. 2007; 115:1306–1324
Bazett HC. An analysis of the time-relations of electrocardiograms. Heart-J Stud Circ. 1920; 7: 353–370
Tutar HE, Ocal B, Imamoglu A, et al.: Dispersion of QT and QTc interval in healthy children, and effects of sinus arrhythmia on QT dispersion. Heart. 1998; 80:77–79
Towbin JA, Gajarski RJ: Cardiac troponin I: A new diagnostic gold standard of cardiac injury in children? J Pediatr. 1997; 130:853–855
Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med. 1998; 339:321–328
Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis: International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6:2–8
Byrne L, Obonyo NG, Diab SD, et al.: Unintended consequences: Fluid resuscitation worsens shock in an ovine model of endotoxemia. Am J Respir Crit Care Med. 2018; 198:1043–1054
Guideline: Updates on Paediatric Emergency Triage, Assessment and Treatment: Care of Critically-Ill Children. In: World Health Organization (Ed). Geneva, Switzerland, World Heatlh Organization, 2016
Opiyo N, Molyneux E, Sinclair D, et al.: Immediate fluid management of children with severe febrile illness and signs of impaired circulation in low-income settings: A contextualised systematic review. BMJ Open. 2014; 4:e004934
Guyatt GH, Oxman AD, Kunz R, et al.; GRADE Working Group: GRADE guidelines: 8. Rating the quality of evidence–indirectness. J Clin Epidemiol. 2011; 64:1303–1310
Ford N, Hargreaves S, Shanks L: Mortality after fluid bolus in children with shock due to sepsis or severe infection: A systematic review and meta-analysis. PLoS One. 2012; 7:e43953
Mehta NJ, Khan IA, Gupta V, et al.: Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol. 2004; 95:13–17
ver Elst KM, Spapen HD, Nguyen DN, et al.: Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem. 2000; 46:650–657
Sheyin O, Davies O, Duan W, et al.: The prognostic significance of troponin elevation in patients with sepsis: A meta-analysis. Heart Lung. 2015; 44:75–81
Soldin SJ, Murthy JN, Agarwalla PK, et al.: Pediatric reference ranges for creatine kinase, CKMB, Troponin I, iron, and cortisol. Clin Biochem. 1999; 32:77–80
Maack T: The broad homeostatic role of natriuretic peptides. Arq Bras Endocrinol Metabol. 2006; 50:198–207
Price JF, Thomas AK, Grenier M, et al.: B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation. 2006; 114:1063–1069
Gangnus T, Burckhardt BB: Potential and limitations of atrial natriuretic peptide as biomarker in pediatric heart failure-A comparative review. Front Pediatr. 2018; 6:420
Kotby AA, Taman KH, Sedky HT, et al.: Atrial natriuretic peptide as a marker of heart failure in children with left ventricular volume overload. J Paediatr Child Health. 2013; 49:43–47
Chappell D, Bruegger D, Potzel J, et al.: Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit Care. 2014; 18:538
Cowman MK, Lee HG, Schwertfeger KL, et al.: The content and size of hyaluronan in biological fluids and tissues. Front Immunol. 2015; 6:261